Skip To Main Content
Marta Munoz on Muck Rack

Marta Munoz

  • Sustainability Business Advisor, Amazon Web Services (AWS)
Madrid, Spain
As seen in: Nature, Wiley Online Library, El Mundo, Frontiers in Marine Science, MDPI, International Data Corporation (IDC), VAVEL Spain, Hoy, Rebelion, Dialnet - Universidad de La Rioja and
#Sustainability&Technology expert @AWS, pistachio farmer, full time mum. Keen on showing how #tech can help orgs achieve #sustainability. Views are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marta

Contact Marta, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mal d’alçada

|
By Ana Armas, Marta Munoz, Marta Muñoz Verified, Lorenzo Armas
| Dialnet - Universidad de La Rioja
IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
Open in Who Shared View Duplicates (696) Issue with article?

Riesgo cardiovascular global en el adulto joven del policlínico Carlos Juan Finlay de Santiago de Cuba

|
By Yanet Veranes Mustelier, Oneida Terazón Miclín, Marta Munoz, Marta Muñoz Verified
| Dialnet - Universidad de La Rioja
Introducción: Las enfermedades cardiovasculares constituyen la primera causa de muerte y discapacidad en el mundo. El riesgo cardiovascular global en adultos jóvenes es un tema poco estudiado en la atención primaria de salud en Cuba. Siendo uno de los problemas de base la aterosclerosis, que avanza con el pasar de los años, por lo que cuando aparecen los síntomas, suele estar ya en una fase avanzada.
Open in Who Shared Issue with article?

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus

|
By Aida Tort-Miró, David Marín-Moraleda, Jordana Munoz-Basagoiti, Yan Zeng, María Navas, Marta Munoz, Marta Muñoz Verified, Beatriz Martín-Mur, Marc Caballé, Anna Esteve-Codina, Virginia Aragón, Enric Vidal, Àlex Cobos, Francesc Accensi, Elena Garcia-Fruitós, Fernando Rodriguez, Fernando Rodríguez Verified, Jordi Argilaguet, Sergio Montaner-Tarbes, Paula Monleon, Judith González-Oliver, Margarita Artigues, Sonia Pina-Pedrero
| Nature Verified
Abstract While effective subunit vaccines against African swine fever (ASF) are still under development, live attenuated vaccines (LAVs) remain the only approach capable of inducing robust protective immunity, though biosafety concerns limit their field use. Thus, further research is required to improve LAV safety while maintaining its immunogenicity.
Open in Who Shared Issue with article?
See all 154 licensed articles (156 Total)